Vanberra Signal

Aureus Sciences

Curated by Signal

Knowledge Management Systems for drug discovery research

Overview

Aureus Science has developed a Knowledge Production Platform which analyzes, indexes and organizes critical chemical and bioactivity information into databases. The company’s products are AurQUEST, a query management software that allows the extraction of information relevant to drug discovery; AurPROFILER that searches across various knowledge bases to identify target, cell, or drug/compound profiles; DDI Predict, which predicts drug-drug interactions between proprietary drugs and a panel of drugs; and AurPASS that predicts biological activity profiles for selected compounds. Its platform contains various databases, including ADME database, GPCR database, GPS database, ion channel database, kinase database, nuclear receptors database, and protease database. As of January 8, 2013, Aureus Sciences SA was acquired by Elsevier B.V

Key facts

Founded
2000
Headquarters
Paris, France

More on Vanberra Signal

Members only
  • AI based platform offering content creation solutions for businesses

    Enterprise Software & InfrastructureFrance
  • Cloud-based employee benefits administration

    Enterprise Software & InfrastructureParis, France
  • Provider of software to enable autonomy in robots

    Enterprise Software & InfrastructureParis, France

About Aureus Sciences

What does Aureus Sciences do?

Aureus Science has developed a Knowledge Production Platform which analyzes, indexes and organizes critical chemical and bioactivity information into databases.

Where is Aureus Sciences headquartered?

Aureus Sciences is headquartered in Paris, France.

When was Aureus Sciences founded?

Aureus Sciences was founded in 2000.

Which sector is Aureus Sciences in?

Aureus Sciences operates in Enterprise Software & Infrastructure.

Who are Aureus Sciences's competitors?

Companies similar to Aureus Sciences include ManaScriber, Collaborative Perks, and Scortex.